The inhaled route is critical for the administration of drugs to treat patients suffering from
COPD, but there is still an unmet need for new and innovative inhalers to address some …

Since chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
obstruction, inhaled bronchodilators form the mainstay of treatment. A variety of new inhaled …

Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

A variety of inhaler devices are available for delivering treatments to patients with chronic
obstructive pulmonary disease, and new inhalers are currently being developed. Each type …

Objectives To integrate evidence from randomised controlled trials (RCTs) and
observational studies on the efficacy of inhaled treatments for chronic obstructive pulmonary …

Abstract The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was formed in
the late 1990s to spread awareness of chronic obstructive pulmonary disease (COPD) as a …

Placing specialists at the cutting-edge of therapeutic and biotechnological research, this
reference reviews the extensive array of pharmaceutical options available for the …

Chronic obstructive pulmonary disease (COPD) is highly prevalent and will continue to be
an increasing cause of morbidity and mortality worldwide. COPD is now viewed under a new …

Chronic obstructive pulmonary disease (COPD) is increasing in the United States and
throughout the world. There have been a number of advances in the treatment of this …

Chronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent
research focusing on its pathophysiology has provided direction for the development of new …